| Design of a conformationally defined and proteolytically stable circular mimetic of brain-derived neurotrophic factor. | |
| | |
MedLine Citation:
|
PMID: 18809686 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family of neurotrophic factors. BDNF has long been recognized to have potential for the treatment of a variety of human neurodegenerative diseases. However, clinical trials with recombinant BDNF have yet to yield success, leading to the suggestion that alternative means of harnessing BDNF actions for therapeutic use may be required. Here we describe an approach to create low molecular weight peptides that, like BDNF, promote neuronal survival. The peptides were designed to mimic a cationic tripeptide sequence in loop 4 of BDNF shown in previous studies to contribute to the binding of BDNF to the common neurotrophin receptor p75NTR. The best of these peptides, the cyclic pentapeptide 2 (cyclo(-D-Pro-Ala-Lys-Arg-)), despite being of low molecular weight (Mr 580), was found to be an effective promoter of the survival of embryonic chick dorsal root ganglion sensory neurons in vitro (maximal survival, 68 +/- 3% of neurons supported by BDNF). Pentapeptide 2 did not affect the phosphorylation of either TrkB (the receptor tyrosine kinase for BDNF) or the downstream signaling molecule MAPK, indicating that its mechanism of neuronal survival action is independent of TrkB. NMR studies reveal that pentapeptide 2 adopts a well defined backbone conformation in solution. Furthermore, pentapeptide 2 was found to be effectively resistant to proteolysis when incubated in a solution of rat plasma in vitro. These properties of pentapeptide 2 (low molecular weight, appropriate pharmacological actions, a well defined solution conformation, and proteolytic stability) render it worthy of further investigation, either as a template for the further design of neuronal survival promoting agents or as a lead compound with therapeutic potential in its own right. |
| | |
Authors:
|
Jordan M Fletcher; Craig J Morton; Richard A Zwar; Simon S Murray; Paul D O'Leary; Richard A Hughes |
Related Documents
:
|
11591126 - The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkb ... 15131306 - Structure of nerve growth factor complexed with the shared neurotrophin receptor p75. 6427216 - A mr 70,000 phosphoprotein of sympathetic neurons regulated by nerve growth factor and ... 17965066 - Brain-derived neurotrophic factor amplifies neurotransmitter responses and promotes syn... 1331816 - The effect of chronic treatment with peripheral benzodiazepine receptor ligands on beha... 11196086 - Mechanism of refractory ceramic fiber- and rock wool-induced cytotoxicity in alveolar m... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2008-09-22 |
Journal Detail:
|
Title: The Journal of biological chemistry Volume: 283 ISSN: 0021-9258 ISO Abbreviation: J. Biol. Chem. Publication Date: 2008 Nov |
Date Detail:
|
Created Date: 2008-11-25 Completed Date: 2009-01-29 Revised Date: 2010-09-21 |
Medline Journal Info:
|
Nlm Unique ID: 2985121R Medline TA: J Biol Chem Country: United States |
Other Details:
|
Languages: eng Pagination: 33375-83 Citation Subset: IM |
Affiliation:
|
Department of Pharmacology, University of Melbourne, Victoria 3010, Australia. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Biomimetic Materials / chemical synthesis, chemistry, pharmacology* Brain-Derived Neurotrophic Factor* Cell Line Cell Survival / drug effects Chick Embryo Drug Design* Enzyme Activation / drug effects Extracellular Signal-Regulated MAP Kinases / metabolism Ganglia, Spinal / cytology, metabolism Humans Neurodegenerative Diseases / drug therapy*, metabolism Neurons / metabolism Oligopeptides / chemical synthesis, chemistry, pharmacology* Protein Structure, Secondary Rats Receptor, Nerve Growth Factor / metabolism Receptor, trkB / metabolism |
| Chemical | |
Reg. No./Substance:
|
0/Brain-Derived Neurotrophic Factor; 0/Oligopeptides; 0/Receptor, Nerve Growth Factor; EC 2.7.10.1/Receptor, trkB; EC 2.7.11.24/Extracellular Signal-Regulated MAP Kinases |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Snake phospholipase A2 neurotoxins enter neurons, bind specifically to mitochondria, and open their ...
Next Document: Two active forms of Zymomonas mobilis levansucrase. An ordered microfibril structure of the enzyme p...